sarcosine has been researched along with methotrexate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frank, N; Osswald, H | 1 |
| Asch, AS; Chen, X; Green, T; Ruiz-EchevarrÃa, MJ; Ryan, S | 1 |
2 other study(ies) available for sarcosine and methotrexate
| Article | Year |
|---|---|
Sacrosine- and prolinedithiocarbamate pretreatment increases the therapeutic efficacy of doxorubicin, methotrexate, teniposide, mitoxantrone or cyclohexylchloroethylnitrosourea in leukemia L1210.
Topics: Animals; Antineoplastic Agents; Cysteine; Doxorubicin; Drug Synergism; Female; Leukemia L1210; Lomustine; Methotrexate; Mice; Mice, Inbred DBA; Mitoxantrone; Proline; Sarcosine; Teniposide; Thiocarbamates | 1990 |
TMEFF2 and SARDH cooperate to modulate one-carbon metabolism and invasion of prostate cancer cells.
Topics: Antimetabolites, Antineoplastic; Carbon; Cell Proliferation; Cell Transformation, Neoplastic; Gene Knockdown Techniques; Humans; Male; Membrane Proteins; Methotrexate; Neoplasm Invasiveness; Neoplasm Proteins; Prostate; Prostatic Neoplasms; Sarcosine; Sarcosine Dehydrogenase; Tumor Cells, Cultured; Tumor Suppressor Proteins | 2013 |